Latest Compliance News

Many Peaks Minerals has delivered a maiden Mineral Resource Estimate of 1.3 million ounces of gold at its Ferké Gold Project in Côte d’Ivoire, predominantly in high-confidence categories and supported by ongoing drilling and development work.

SRJ Technologies has locked in a three-year, US$4.4 million deal to deploy its robotic leak detection and emissions inspection services for a major UAE state-owned oil and gas operator, following a successful proof-of-concept trial.

African Gold Ltd has secured Supreme Court approval for its share and option schemes under the Montage Gold acquisition, setting a clear path to finalise the takeover by late April.

The ASX has published its latest roster of over 40 entities suspended for more than three months, detailing looming deadlines for overdue reports and trading resumption plans. Failure to meet these could trigger removal from the official list.

Brisbane Broncos Limited celebrated a landmark 2025 with premiership victories in both the NRL and NRLW, driving a 36% jump in net profit to $7.77 million and underpinning strong commercial growth.

Highfield Resources (ASX:HFR) has dismissed any undisclosed material information as the cause of its recent share price jump, attributing the volatility to global geopolitical tensions impacting fertiliser raw materials.

Insignia Financial’s $3.3 billion acquisition by CC Capital Partners has cleared its final legal hurdle, with the Federal Court approving the scheme of arrangement and share trading set to suspend imminently. Shareholders on record will receive $4.80 per share when the deal completes later this month.

Electro Optic Systems (ASX: EOS) wraps up a three-year turnaround, reporting a $459 million order backlog despite a 27% revenue drop. The company expands its counter-drone and space control portfolio with the acquisition of the UK-based Interceptor business and a pending deal for MARSS, a European command-and-control software provider.

Atomo Diagnostics has responded to ASX queries confirming it first held market-sensitive information after Lumos Diagnostics’ FDA CLIA waiver approval for FebriDx. The company defended its trading halt and capital raise timing, asserting full compliance with ASX Listing Rules.

Multistack International has formalised the sale of nearly all its assets and liabilities to Hong Kong-based Willing Y Limited, marking a decisive end to its loss-making operations. The transaction hinges on shareholder and regulatory approvals, with completion targeted for June 30, 2026.

Emu NL's EMUOA securities have been suspended from trading by the ASX, pending compliance with listing rules. This move affects only the EMUOA class and signals regulatory scrutiny ahead of the company's next steps.

Proteomics International Laboratories has slashed a quarter of its workforce and appointed a new CFO amid a strategic pivot to commercial diagnostics, aiming to save over $1 million annually and sharpen execution.